Lynch SP et al (2012) Multifocality and multicentricity in breast cancer and survival outcomes. Ann Oncol 23(12):3063–3069

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wolters R et al (2013) Comparing the outcome between multicentric and multifocal breast cancer: what is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients. Breast Cancer Res Treat 142(3):579–590

Article  CAS  PubMed  Google Scholar 

Dawson PJ, Baekey PA, Clark RA (1995) Mechanisms of multifocal breast cancer: an immunocytochemical study. Hum Pathol 26(9):965–969

Article  CAS  PubMed  Google Scholar 

Middleton LP et al (2002) Multicentric mammary carcinoma: evidence of monoclonal proliferation. Cancer 94(7):1910–1916

Article  PubMed  Google Scholar 

Desmedt C et al (2015) Uncovering the genomic heterogeneity of multifocal breast cancer. J Pathol 236(4):457–466

Article  CAS  PubMed  PubMed Central  Google Scholar 

Norton N et al (2016) Assessment of Tumor Heterogeneity, as evidenced by Gene expression profiles, pathway activation, and Gene Copy Number, in patients with multifocal invasive lobular breast tumors. PLoS ONE 11(4):e0153411

Article  PubMed  PubMed Central  Google Scholar 

Goldhirsch A et al (2011) Strategies for subtypes–dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the primary therapy of early breast Cancer 2011. Ann Oncol 22(8):1736–1747

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lester SC et al (2009) Protocol for the examination of specimens from patients with invasive carcinoma of the breast. Arch Pathol Lab Med 133(10):1515–1538

Article  PubMed  Google Scholar 

Buggi F et al (2012) Multicentric/multifocal breast cancer with a single histotype: is the biological characterization of all individual foci justified? Ann Oncol 23(8):2042–2046

Article  CAS  PubMed  Google Scholar 

Janeva S et al (2023) Clinical evaluation of molecular surrogate subtypes in patients with ipsilateral multifocal primary breast cancer. Breast Cancer Res 25(1):36

Article  CAS  PubMed  PubMed Central  Google Scholar 

Navale P et al (2019) Evaluation of biomarkers in multiple ipsilateral synchronous invasive breast carcinomas. Arch Pathol Lab Med 143(2):190–196

Article  CAS  PubMed  Google Scholar 

Mosbah R et al (2015) Pathological characteristics of both tumors in Bifocal and bicentric breast Cancer. Anticancer Res 35(9):5111–5116

PubMed  Google Scholar 

Boros M et al (2014) Morphologic and molecular subtype status of individual tumor foci in multiple breast carcinoma. A study of 155 cases with analysis of 463 tumor foci. Hum Pathol 45(2):409–416

Article  CAS  PubMed  Google Scholar 

Choi Y et al (2012) The hormone receptor, human epidermal growth factor receptor 2, and molecular subtype status of individual tumor foci in multifocal/multicentric invasive ductal carcinoma of breast. Hum Pathol 43(1):48–55

Article  CAS  PubMed  Google Scholar 

Pekmezci M et al (2013) Evaluation of biomarkers in multifocal/multicentric invasive breast carcinomas. Int J Surg Pathol 21(2):126–132

Article  PubMed  Google Scholar 

Garimella V et al (2007) Oestrogen and progesterone receptor status of individual foci in multifocal invasive ductal breast cancer. Acta Oncol 46(2):204–207

Article  CAS  PubMed  Google Scholar 

Bethune GC, Mullen JB, Chang MC (2013) HER2 testing of multifocal invasive breast carcinoma: how many blocks are enough? Am J Clin Pathol 140(4):588–592

Article  PubMed  Google Scholar 

Tong Y et al (2023) Multifocal/multicentric breast cancer: does each focus matter? Cancer Med 12(7):8815–8824

Article  PubMed  PubMed Central  Google Scholar 

Li S et al (2022) Association of Molecular Biomarker Heterogeneity with Treatment Pattern and Disease outcomes in multifocal or multicentric breast Cancer. Front Oncol 12:833093

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goldhirsch A et al (2013) Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast Cancer 2013. Ann Oncol 24(9):2206–2223

Article  CAS  PubMed  PubMed Central  Google Scholar 

Finsterbusch K et al (2020) Luminal A versus luminal B breast cancer: MammaTyper mRNA versus immunohistochemical subtyping with an emphasis on standardised Ki67 labelling-based or mitotic activity index-based proliferation assessment. Histopathology 76(5):650–660

Article  PubMed  Google Scholar 

Baak JP et al (2008) Proliferation accurately identifies the high-risk patients among small, low-grade, lymph node-negative invasive breast cancers. Ann Oncol 19(4):649–654

Article  CAS  PubMed  Google Scholar 

Focke CM, Decker T, van Diest PJ (2016) The reliability of histological grade in breast cancer core needle biopsies depends on biopsy size: a comparative study with subsequent surgical excisions. Histopathology

Chen X et al (2013) Preoperative core needle biopsy is accurate in determining molecular subtypes in invasive breast cancer. BMC Cancer 13:390

Article  PubMed  PubMed Central  Google Scholar 

Acs B et al (2022) Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study. Mod Pathol 35(10):1362–1369

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wolff AC et al (2018) Human epidermal growth factor receptor 2 testing in breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. J Clin Oncol 36(20):2105–2122

Article  CAS  PubMed  Google Scholar 

Hammond ME et al (2010) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version) Arch. Pathol. Lab Med, 134(7): p. e48-e72

Laible M et al (2016) Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens. BMC Cancer 16:398

Article  PubMed  PubMed Central  Google Scholar 

Pekar G et al (2014) Molecular phenotype of the foci in multifocal invasive breast carcinomas: intertumoral heterogeneity is related to shorter survival and may influence the choice of therapy. Cancer 120(1):26–34

Article  PubMed  Google Scholar 

Wirtz RM et al (2016) Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry. Breast Cancer Res Treat 157(3):437–446

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boros M et al (2012) Morphological heterogeneity of the simultaneous ipsilateral invasive tumor foci in breast carcinoma: a retrospective study of 418 cases of carcinomas. Pathol Res Pract 208(10):604–609

Article  CAS  PubMed  Google Scholar 

Arbeitsgemeinschaft (2023) Gynäkologische Onkologie e.V. Prognostic and Predictive Factors in Breast Cancer (Version 2023.1D) ; Available from: https://www.ago-online.de/fileadmin/ago-online/downloads/_leitlinien/kommission_mamma/2023/englisch/Einzeldateien/AGO_2023E_05_Prognostic_and_predictive_faktors.pdf

National Comprehensive Cancer Network. Breast Cancer (Version 5.2023). (2023) ; Available from: https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf

Allison KH et al (2020) Estrogen and progesterone receptor testing in breast Cancer: ASCO/CAP Guideline Update. J Clin Oncol 38(12):1346–1366

Article  PubMed  Google Scholar 

Wolff AC et al (2023) Human epidermal growth factor receptor 2 testing in breast Cancer: ASCO-College of American Pathologists Guideline Update. J Clin Oncol 41(22):3867–3872

Article  CAS  PubMed  Google Scholar